| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GRTS | Common Stock | Award | $0 | +27.1K | +4.05% | $0.00 | 697K | May 15, 2024 | Direct | F1, F2 |
| transaction | GRTS | Common Stock | Sale | -$10.3K | -13.7K | -1.97% | $0.75 | 684K | May 16, 2024 | Direct | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GRTS | Stock Option (Right to Buy) | Award | $0 | +235K | $0.00 | 235K | May 15, 2024 | Common Stock | 235K | $0.75 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Represents Performance Stock Units ("PSUs") granted on March 22, 2024 that were earned by the Reporting Person as a result of the achievement of certain performance criteria as certified by the Issuer's Board of Directors on May 15, 2024. The PSUs vest over one year; 1/2 vested on May 15, 2024, and thereafter the remaining 1/2 will vest on May 15, 2025, subject to the continuing service of the Reporting Person on such vesting date. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock. |
| F2 | Includes 362,694 Restricted Stock Units ("RSUs") and PSUs which are subject to vesting. |
| F3 | The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of PSUs. |
| F4 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.735 to $0.7616 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The option vests as to 1/2 of the total grant on September 30, 2024, with the remainder of grant vesting on September 30, 2025, subject to the continued service of the Reporting Person on each vesting date. |
EVP, Head of Research and Development